Preoperative C-Reactive Protein and Outcome after Coronary Artery Bypass Surgery

Annals of Thoracic Surgery

Volumn 76, Issue 6, 2003, Pages 2007-2012

  Biancari, Fausto ^a,b   Lahtinen, Jarmo ^a   Lepojärvi, Samuli ^a   Rainio, Pekka ^a   Salmela, Esa ^a   Pokela, Risto ^a   Lepojärvi, Martti ^a   Satta, Jari ^a   Juvonen, Tatu S ^a  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DILATATION; DIABETES MELLITUS; DISEASE SEVERITY; EMERGENCY SURGERY; FEMALE; FORWARD HEART FAILURE; HEART DEATH; HEART EJECTION FRACTION; HEART INFARCTION; HOSPITALIZATION; HUMAN; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0345527044     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)01067-1     Document Type: Article

References (32)

1. Yamashita H, Shimada K, Seki E, Mokuno H, Daida H. Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris. Am J Cardiol 2003;91:133-6.
2. Erren M, Reinecke H, Junker R, Fobker M, et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Atherosclerosis 1999; 19:2355-63.
3. Ablij HC, Meinders AE. C-reactive protein: history and revival. Eur J Intern Med 2002;13:412-22.
4. Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999;99:237-42.
5. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14719 initially healthy american women. Circulation 2003;107:391-7.
6. Rallidis LS, Zolidanski MG, Manioudaki HS, Laoutaris NP, Velissaridou AH, Papasteriadis EG. Prognostic value of C-reactive protein, fibrinogen, interleukin-6, and macrophage colony stimulating factor in severe unstable angina. Clin Cardiol 2002;25:505-10.
7. Zairis MN, Manousakis SJ, Stefanidis AS, et al. C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST-segment elevation acute myocardial infarction. Am Heart J 2002;144:782-9.
8. Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001;32:133-8.
9. Buffon A, Liuzzo G, Biasucci LM, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999;34:1512-21.
10. Chew DP, Bhatt DL, Robbins MA, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 2001;104:992-7.
11. de Winter RJ, Heyde GS, Koch KT, et al. The prognostic value of preprocedural C-reactive protein in patients undergoing elective coronary angioplasty. Eur Heart J 2002;23: 923-5.
12. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffré PA. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol 2000;85:92-5.
13. Walter DH, Fichtlscherer S, Sellwig M, Auch-Schwelk W, Schachninger V, Zeiher AM. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 2001;37:839-46.
14. Gaudino M, Nasso G, Andreotti F, et al. Preoperative C-reactive protein level, and outcome following coronary surgery. Eur J Cardiothorac Surg 2002;22:521-6.
15. Milazzo D, Biasucci LM, Luciani N, et al. Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events. Am J Cardiol 1999;84: 459-61.
16. Baretti R, Pannek N, Knecht JP, Krabatsch T, Hubler S, Hetzer R, Risk stratification scores for predicting mortality in coronary artery bypass surgery. Thorac Cardiovasc Surg 2002;50:237-46.
17. Orr RK, Maini BS, Sottile FD, Dumas EM, O'Mara P. A comparison of four severity-adjusted models to predict mortality after coronary artery bypass graft surgery. Arch Surg 1995;130:301-6.
18. Pinna-Pintor P, Bobbio M, Colangelo S, et al. Inaccuracy of four coronary surgery risk-adjusted models to predict mortality in individual patients. Eur J Cardio-thorac Surg 2002; 21:199-204.
19. Biancari F, Kantonen I, Albäck A, Mätzke S, Luther M, Lepäntalo M. Limits of infrapopliteal bypass surgery for critical leg ischemia: when not to reconstruct. World J Surg 2000;24:727-33.
20. Satta J, Immonen K, Reinila A, Pokela R, Juvonen T. Outcome of elective infrarenal abdominal aortic aneurysm repair: an analysis of 174 consecutive patients. Ann Chir Gynaecol 1996;85:231-5.
21. Schillinger M, Domanovits H, Bayegan K, et al. C-reactive protein, and mortality in patients with acute aortic disease. Intensive Care Med 2002;28:740-5.
22. Aronen M. Value of C-reactive protein in detecting complications after open-heart surgery in children. Scand J Thorac Cardiovasc Surg 1990;24:141-5.
23. Aronen M. Value of C-reactive protein in detecting complications after closed-heart surgery in children. Scand J Thorac Cardiovasc Surg 1990;24:147-51.
24. Boeken U, Feindt P, Zimmerman N, Kalweit G, Petzold T, Emmeran G. Increased preoperative C-reactive protein values without signs of an infection and complicated course after cardiopulmonary bypass operations. Eur J Cardiothoracic Surg 1998;13:541-5.
25. Fransen EJ, Maessen JG, Elenbaas TW, van Aarnhem EE, van Dieijen-Visser MP. Enhanced preoperative C-reactive protein plasma levels as a risk factor for postoperative infections after cardiac surgery. Ann Thorac Surg 1999;67: 134-48.
26. Borolessa H, De Beer FC, Manchie A, Whitwam JG, Pepys MB. C-reactive protein in patients undergoing cardiac surgery. Anaesthesia 1986;41:11-5.
27. Alonso-Martinez JL, Llorente-Diez B, Echegaray-Agara M, Olaz-Preciado F, Urbieta-Echezarreta M, Gonzalez-Arencibia C. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail 2002;4:331-6.
28. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996;27:1201-6.
29. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999;353:1838-42.
30. Pye M, Rae AP, Cobbe SM. Study of serum C-reactive protein concentration in cardiac failure. Br Heart J 1990;63: 228-30.
31. Sato Y, Takatsu Y, Kataoka K, et al. Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clin Cardiol 1999;22:811-3.
32. Anker SD, Volterrani M, Egerer KR, et al. Tumor necrosis factor alpha as a predictor of peak leg blood flow in patients with chronic heart failure. Q J Med 1998;91:199-03.